The Global Health Innovative Technology (GHIT) Fund has awarded VLP Therapeutics a $3.9 million grant to further develop a novel tetravalent dengue virus-like particle vaccine.
{iframe}https://www.prnewswire.com/news-releases/vlp-therapeutics-awarded-3-9-million-grant-by-global-health-innovative-technology-fund-for-further-development-of-dengue-vaccine-300764472.html{/iframe}